# OnCo record photys-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/photys-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "photys-therapeutics" ;
  schema:name "Photys Therapeutics"@en ;
  schema:description "Photys Therapeutics builds two-headed molecules that bring a target protein next to an enzyme that modifies or destroys it. Its first clinical drug is for autoimmune disease; its cancer work, aimed at a mutant form of the p53 protein, is still in the laboratory."@en ;
  schema:url <https://onco.cc/companies/photys-therapeutics/>, <https://www.photys.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.photys.com/>, <https://www.photys.com/sep-08-2022-75million-series-a-funding-for-precision-phosphorylation> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/tp53/> .
